Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Copper Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Discover how copper-catalyzed halogenation reduces costs and improves yield for pharmaceutical intermediates. Scale with NINGBO INNO PHARMCHEM's CDMO expertise.
Eliminate palladium catalysts and anhydrous conditions in vismodegib production. Achieve 99% purity with 50% yield using copper-catalyzed route. Reduce costs by 30%.